Cargando…
Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
Autores principales: | Hawarden, Amy, Russell, Bryn, Gee, Mary Ellen, Kayali, Fatima, Clamp, Andrew, Crosbie, Emma Jayne, Edmondson, Richard John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152121/ https://www.ncbi.nlm.nih.gov/pubmed/34039290 http://dx.doi.org/10.1186/s12885-021-08369-4 |
Ejemplares similares
-
Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
por: Hawarden, Amy, et al.
Publicado: (2021) -
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
por: Mahmood, Reem D., et al.
Publicado: (2020) -
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
por: Morgan, Robert D., et al.
Publicado: (2018) -
A three protein signature fails to externally validate as a biomarker to predict surgical outcome in high-grade epithelial ovarian cancer
por: Hawarden, Amy, et al.
Publicado: (2023) -
The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome
por: Walker, Thomas D. J., et al.
Publicado: (2023)